Impax Laboratories Inc (NASDAQ:IPXL)

46.64
Delayed Data
As of Apr 01
 -0.23 / -0.49%
Today’s Change
22.12
Today|||52-Week Range
47.70
+47.22%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close46.87
Today’s open46.57
Day’s range45.25 - 46.70
Volume988,418
Average volume (3 months)687,539
Market cap$3.3B
Dividend yield--
Data as of 3:59pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+13.19%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+16.53%
P/E ratio57.4
Price/Sales3.62
Price/Book3.76

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+0.19+0.48%
ACADACADIA Pharmaceutica...-0.55-1.69%
HZNPHorizon Pharma PLC+0.04+0.15%
ASPXAuspex Pharmaceutica...+0.04+0.04%
Data as of 3:59pm ET, 04/01/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.16
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account